自发肌内血瘤:一个单一中心的回顾性研究和建议的管理算法
Malin Gunawardena1, Abubaker Elamin2,3
1General Surgery, Università degli Studi di Milano, Milan, ITA.
Cureus
|December 9, 2024
概括
自发性肌内血瘤,通常与抗凝剂有关,可以通过非手术治疗或栓塞有效管理. 较高的血小板计数可以防止出血,而男性则经历了更长的住院时间.
科学领域:
- 血管外科 血管外科
- 干预性放射学 干预性放射学
- 紧急医疗 紧急医疗
背景情况:
- 自发性肌内血瘤没有已知的原因,不包括创伤或疾病.
- 发病率正在上升,部分原因是使用抗凝剂.
- 最佳的管理策略缺乏高级别的证据.
研究的目的:
- 为了评估自发性肌内血瘤的治疗结果.
- 确定影响患者结果和住院时间的因素.
主要方法:
- 对31名被诊断患有自发肌内血瘤的患者 (2013-2017年) 的回顾性分析.
- 收集的数据包括患者的特征,生命体,实验室,成像和结果.
- 治疗方法包括动脉栓塞和非手术治疗.
主要成果:
- 较高的血小板计数与预防出血相关.
- 动脉栓塞取得了很高的技术 (94%) 和临床 (81%) 成功.
- 非手术治疗与住院时间显著缩短有关.
结论:
- 非手术治疗和栓塞对于自发性血液瘤是有效的.
- 需要进一步的多中心和前性研究来确认发现并优化后续行动.
相关概念视频
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


